Dr. Guy Chamberland, CEO and Chief Regulatory Officer, Tetra Bio-Pharma Inc. (TSX:TBP), joined his team and Sophie Van Houtte, Head of Company Services, TMX Group, to celebrate the company’s graduation from TSX Venture Exchange to Toronto Stock Exchange and open the market.
Tetra Bio-Pharma is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved and FDA reviewed and cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. With patients at the core of what they do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information, please visit www.tetrabiopharma.com. …...more
...more
Show less
